Skip to content

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Markets

  • Before July 2027

    • Yes86%
    • No14%

    Volume $8.7K · Liquidity $3.3K

  • Before Jan 1, 2027

    • Yes22%
    • No78%

    Volume $7K · Liquidity $3.5K

  • Before Mar 1, 2027

    • Yes65%
    • No35%

    Volume $4.5K · Liquidity $2.9K

  • Before October 2027

    • Yes83%
    • No17%

    Volume $2.4K · Liquidity $1K

  • Before 2028

    • Yes92%
    • No8%

    Volume $1.1K · Liquidity $554.7

Resolution rules

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

How to read these odds

Each price runs from $0 to $1 and can be read as the probability the market assigns to an outcome: $0.62 means roughly 62%. Prices move with every trade, so they are a crowd estimate, not a guarantee. Before trading, check the resolution rules above, the volume and the liquidity, and only risk money you can afford to lose.

Probability calculators · Glossary · Free courses